Core Competence Intervention: BD (Becton, Dickinson and Company) - TB (2008) | Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria

Tools

Core Competence Intervention: BD (Becton, Dickinson and Company) - TB (2008)

Executive Summary

BD and the Foundation for Innovative New Diagnostics (FIND) improved TB diagnostics in 39 countries by providing the technology and technical assistance necessary to access new and more accurate diagnostic tools. A pricing agreement with FIND not only enabled BD to provide technology on an affordable and sustainable basis, but also enabled the company to build long-term relationships with emerging healthcare systems.

Company Overview

BD is a global medical technology company that manufactures and sells medical devices, instrument systems, and reagents. The company is dedicated to improving people’s health throughout the world and is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious disease, advancing research, and discovering new drugs and vaccines.

The full content for this page is available to Coalition members only.

If your company is currently a member, you may login using the form below, or register to receive your username.

» Visit the registration page to request a username and password

If your company is not a Coalition member, we encourage you to learn more about how GBC membership will help you achieve more in the fight against AIDS, TB and malaria.

» Read more about the benefits of GBC membership

Tools